Keywords: تکرار کیناز 2 غنی از لوسین; Parkinson's disease; Ghrelin; Dementia; AHN; adult hippocampal neurogenesis; AD; Alzheimer's Disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPK; AMP-activated protein kinase; AB; amyloid-β; ATG; autophagy-related; BBB; blood brain
مقالات ISI تکرار کیناز 2 غنی از لوسین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تکرار کیناز 2 غنی از لوسین; Aβ; beta-amyloid; APOE; apolipoprotein E; APP; amyloid precursor protein; AD; Alzheimer's disease; CRISPR; clustered regularly interspaced short palindromic repeats; DAT; dopamine transporter; ER; estrogen receptor; FAD; familial Alzheimer's disease;
Keywords: تکرار کیناز 2 غنی از لوسین; 6-OHDA; 6-hydroxydopamine; Aβ; amyloid-β; AD; Alzheimer disease; ALS; amyotrophic lateral sclerosis; APOE4; apolipoprotein E4; APP; amyloid precursor protein; ASCL1; achaete-scute family basic helix-loop-helix transcription factor 1; ATP; adenosine trip
Keywords: تکرار کیناز 2 غنی از لوسین; BBB; blood-brain barrier; CSF; cerebral spinal fluid; COX1; cyclo-oxygenase 1; COX2; cyclo-oxygenase 2; CRP; C reactive protein; DA; dopamine; EGF; Epidermal growth factor; FACIT; functional assessment of chronic illness therapy; FcγRII; Fc gamma recepto
Keywords: تکرار کیناز 2 غنی از لوسین; Polyphenols; Antibiotics; Antioxidants; PACAP; Aβ; β-amyloid; AD; Alzheimer's disease; AMPK; AMP-activated protein kinase; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; CAT; catalase; CNS; central nervous system; COX-2; cyclooxyge
Keywords: تکرار کیناز 2 غنی از لوسین; sEH; soluble epoxide hydrolase; mEH; microsomal epoxide hydroxylases; EETs; Epoxyeicosatrienoic acids; PD; Parkinson's disease; SNCA; synuclein alpha; LRRK2; leucine-rich repeat kinase 2; PARK2; E3 ubiquitin-protein ligase parkin; PINK1; PTEN induced pu
Keywords: تکرار کیناز 2 غنی از لوسین; AAO; age at onset; CIs; confidence intervals; GBA; glucocerebrosidase; LRRK2; leucine-rich repeat kinase 2; MAPT; microtubule-associated protein tau; NOS; Newcastle-Ottawa Scale; ORs; odds ratios; PD; Parkinson's disease; SNCA; a-Synuclein; meta-analy
Keywords: تکرار کیناز 2 غنی از لوسین; BD; Bipolar Disorder; STEP-BD; Systematic Treatment Enhancement Program for Bipolar disorder; DFNB31; Deafness, Autosomal Recessive 31; SORCS2; Sortilin-Related VPS10 Domain Containing Receptor 2; NRXN1; Neurexin 1; CNTNAP2; Contactin Associated Protein-L
Keywords: تکرار کیناز 2 غنی از لوسین; OS; oxidative stress; CNS; central nervous system; ROS; reactive oxygen species; SOD; superoxide dismutase; CAT; catalase; Cu; copper; Zn; zinc; Mn; manganese; Fe; iron; Ni; nickel; DA; dopamine; PHOX; NADPH oxidase; Nrf2; nuclear factor erythroid 2-relat
Keywords: تکرار کیناز 2 غنی از لوسین; 6MWT; six-minute walking test; 6-OHDA; 6-hydroxydopamine; 9HPT; 9-hole peg test; ACE; Addenbrooke's cognitive examination; ADLs; activities of daily life; AIMS; abnormal involuntary movement scale; ASI; anxiety status inventory; ASs; autonomic symptoms; B
Keywords: تکرار کیناز 2 غنی از لوسین; Dendritic spine; Synaptic plasticity; Neurodegenerative diseases; Psychiatric disorders; Glutamate receptor; Calcium signaling; ADHD; attention deficit hypersensitive disorders; FXS; Fragile X-syndrome; CNS; central nervous system; GABA; gamma amino butyr
Keywords: تکرار کیناز 2 غنی از لوسین; Catecholamine; Dopamine; Norepinephrine; Parkinson's disease; Neurodegeneration; AAG; autoimmune autonomic ganglionopathy; ALDH; aldehyde dehydrogenase; AMYL; amyloidosis; CAF; chronic autonomic failure; DA; dopamine; DHPG; 3,4-dihydroxyphenylglycol; DOPA
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; Chelation-enhanced fluorescence; Parkinson’s disease; LRRK2 mutations; LRRK2 kinetics
Keywords: تکرار کیناز 2 غنی از لوسین; AD; Alzheimer disease; Aβ; amyloid-β; APP; amyloid-β protein precursor; ADDL; Aβ-derived diffusible ligand; ApoE4; apolipoprotein E; COX; cytochrome c oxidase; DLP1, aka Drp1; dynamin-like protein 1; ETC; electron transport chain; LHON; Leber's heredi
Keywords: تکرار کیناز 2 غنی از لوسین; AKAP1; A kinase anchoring protein 1; Endo B1; endophilin B1; ER; endoplasmic reticulum; GDAP1; ganglioside-induced differentiation-associated protein 1; GED; GTPase effector domain; GFP; green fluorescent protein; KO; knockout; LRRK2; leucine-rich repeat
Keywords: تکرار کیناز 2 غنی از لوسین; SNc; substantia nigra pars compacta; PD; Parkinson disease; NMS; nonmotor symptoms; MAO-B; monoamine oxidase-B; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA; 6-hydroxy dopamine; GBA; glucocerebrosidase; STN
The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition
Keywords: تکرار کیناز 2 غنی از لوسین; Park8; Dardarin; Pharmacodynamics; Pharmacokinetics; Small-molecule inhibitor; LRRK2; Leucine-rich repeat kinase 2; PD; Parkinson disease; ATP; adenosine-tri phosphate; DTT; dithiothreitol; HSC70; Heat-shock cognate 70; Rab; Ras gene from rat brain, or Ra
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice
Keywords: تکرار کیناز 2 غنی از لوسین; α-synuclein; G2019S knock-in mice; iba-1; LRRK2; Microglia; Parkinson's disease; AAV2/9; adeno-associated viral vector pseudotype 2/9; DA; dopamine; G2019S knock-in; G2019S KI; hα-syn; p.A53T human α-synuclein; ionized calcium binding adaptor molecule
Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner
Keywords: تکرار کیناز 2 غنی از لوسین; 5-HT; 5-hydroxytryptamine; Aβ; β-amyloid; ABCA8; ATP binding cassette subfamily A member 8; AD; Alzheimer's disease; ADP; adenosine diphosphate; AGD; argyrophilic grain disease; ALS; amyotrophic lateral sclerosis; AMBRA-1; autophagy and beclin 1 regul
Novel and functional ATG12 gene variants in sporadic Parkinson's disease
Keywords: تکرار کیناز 2 غنی از لوسین; PD; Parkinson's disease; ATG; autophagy-related gene; DSVs; DNA sequence variants; SNCA; alpha synuclein gene; LRRK2; leucine-rich repeat kinase 2; VPS35; vacuolar protein sorting 35; PINK1; PTEN-induced kinase 1; GBA; Glucocerebrosidase; CMA; chaperone-m
Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease
Keywords: تکرار کیناز 2 غنی از لوسین; Cognitive impairment; Idiopathic Parkinson's disease; Leucine-rich repeat kinase 2; Genetic risk factor; Polymorphism;
CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
Keywords: تکرار کیناز 2 غنی از لوسین; LRRK2-G2019S; CRISPR/Cas9; piggyBac; Parkinson's disease; hiPS; α-Synuclein; Serine129 phosphorylated α-Synuclein; PD; Parkinson's disease; LRRK2; leucine-rich repeat kinase 2; G2019S; Glycine 2019 mutated to Serine; SNpc; substantia nigra pars compacta
Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice
Keywords: تکرار کیناز 2 غنی از لوسین; ChaRP; challenge-adjusted rod performance; ITI; inter-trial interval; LRRK2; leucine-rich repeat kinase 2; NAD; novel arm discrimination; ORP; overall rod performance; PD; Parkinson's disease; PSD-95; post synaptic density protein; RAWM; radial arm wate
Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide
Keywords: تکرار کیناز 2 غنی از لوسین; Microglial priming; Aging; Parkinson's disease; MMP-8 inhibitor; Systemic inflammation; Neuroinflammation; CSF; macrophage colony-stimulating factor; EMSA; electrophoretic mobility shift assay; GFAP; glial fibrillary acidic protein; Iba1; ionized calcium
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Keywords: تکرار کیناز 2 غنی از لوسین; COR; C-terminal of Ras; CSF; cerebral spinal fluid; DAT-1; dopamine transporter-1; ERK5; extracellular-signal-regulated kinase 5; ExAC; Exome Aggregation Consortium; GTPase; Guanosine Triphosphate Hydrolase; LoF; loss of function; LRRK2; leucine-rich repe
Analysis of mitochondrial structure and function in the Drosophila larval musculature
Keywords: تکرار کیناز 2 غنی از لوسین; ATP; adenosine triphosphate; AEL; after egg laying; CMT2A; Charcot-Marie-Tooth Type 2A; ConA; concanavalin A; Drp1; dynamin-related protein; DOA; dominant optic atrophy; GFP; green fluorescent protein; IFM; indirect flight muscle; IMF; intermyofibrill
Intracellular Ca2+ signaling and Ca2+ microdomains in the control of cell survival, apoptosis and autophagy
Keywords: تکرار کیناز 2 غنی از لوسین; Apoptosis; Autophagy; Endoplasmic reticulum; IP3 receptor; Lysosomes; Mitochondria; AMBRA1; autophagy/Beclin 1 regulator 1; AMPK; AMP-activated kinase; ATF4; activating transcription factor-4; Atg; autophagy-related; BIRD-2; Bcl-2/IP3R disruptor-2; CREB;
Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases
Keywords: تکرار کیناز 2 غنی از لوسین; ÎΨm; membrane potential; AD; Alzheimer's disease; AMPK; adenosine-monophosphate-activated kinase; ATG proteins; autophagy-related proteins; ATP; adenosine triphosphate; CaMKs; calcium-calmodulin-activated kinases; CDKs; cyclin-dependent kinases; CNS;
Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; Parkinson's disease; Neurodegeneration; Inflammation; Oxidative stress;
Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers
Keywords: تکرار کیناز 2 غنی از لوسین; ANOVA; analysis of variance; BSA; bovine serum albumin; ERM; ezrin/radixin/moesin; FSC; forward scatter; HBSS; Hanks balanced salt solution; LatA; Latrunculin A; LRRK2; leucine-rich repeat kinase 2; PBS; phosphate-buffered saline; PD; Parkinson's diseas
Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation
Keywords: تکرار کیناز 2 غنی از لوسین; Aβ; amyloid beta; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; ATP; adenosine triphosphate; Bci3; Bax cannel inhibitor 3; cAMP; cyclic adenosine monophosphate; CMA; chaperone-mediated autophagy; DLB; dement
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging
Keywords: تکرار کیناز 2 غنی از لوسین; BAC; bacterial artificial chromosome; DA; dopamine; KI; knock-in; KD; kinase dead; LRRK2; leucine-rich repeat kinase 2; PD; Parkinson's disease; ROC; Ras Of Complex; WT; wild-type; Aging; D1994S knock-in; G2019S knock-in; H-1152; LRRK2 kinase-dead; LRRK2;
Zebrafish as a model system for mitochondrial biology and diseases
Keywords: تکرار کیناز 2 غنی از لوسین; 2,5-DHBA; 2,5-dihydroxybenzoic acid; ALS; amyotrophic lateral sclerosis; ATP; adenosine triphosphate; Bcl-2; B-cell lymphoma 2; CMT2; Charcot-Marie-Tooth 2; CNS; central nervous system; coA; coenzyme A; COX; cytochrome c oxidase; DA; dopaminergic; dpf; da
Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; LRRK2; LRRK2 inhibitors; Kinase inhibitors; Parkinson's disease;
The development of CNS-active LRRK2 inhibitors using property-directed optimisation
Keywords: تکرار کیناز 2 غنی از لوسین; PD; Parkinson's disease; LRRK2; leucine-rich repeat kinase 2; DLP1; dynamin-like protein 1; FOXO1; forkhead box transcription factor; 4E-BP; eukaryotic initiation factor 4E (eIF4E)-binding protein; SBDD; structure-based drug design; HTS; high throughput
ATP-competitive LRRK2 inhibitors interfere with monoclonal antibody binding to the kinase domain of LRRK2 under native conditions. A method to directly monitor the active conformation of LRRK2?
Keywords: تکرار کیناز 2 غنی از لوسین; IP; immunoprecipitates; LRRK2; leucine-rich repeat kinase 2; PD; Parkinson's disease; Roc; Ras of complex protein; SILAC; stable isotope labeling of amino acids in culture; LRRK2; Kinase domain; Activation segment; Conformation; Antibody; Immunoprecipitat
Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity
Keywords: تکرار کیناز 2 غنی از لوسین; LRRK2; leucine-rich repeat kinase 2; DAT; dopamine transporter; DA; dopamine; Mn; manganese; HEK; human embryonic kidney; ROS; reactive oxygen species; JNK; c-Jun N-terminal kinases; p38; 38 mitogen-activated protein kinase; AP13A2; probable cation-transp
Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation
Keywords: تکرار کیناز 2 غنی از لوسین; LRRK2; leucine-rich repeat kinase 2; PD; Parkinson's disease; S910/935; serine 910/935; HEK293; human embryonic kidney 293; FCS; fetal calf serum; PBMC; peripheral blood mononuclear cell; HRP; horseradish-peroxidase; LC-MS/MS; liquid chromatography mass
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4
Keywords: تکرار کیناز 2 غنی از لوسین; F-actin; filamentous actin; G-actin; globular actin; LIMK; LIM domain kinase; LRRK2; leucine-rich repeat kinase 2; PAK; p21 protein (Cdc42/Rac)-activated kinase; qRT-PCR; quantitative reverse transcription polymerase chain reaction; GEF; guanine nucleotid
LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: Suppression by curcumin
Keywords: تکرار کیناز 2 غنی از لوسین; PD; Parkinson disease; LRRK2; leucine-rich repeat kinase 2; ROC; Ras of complex proteins; TH; tyrosine hydroxylase; PAL; protocerebral antero lateral; PAM; paired anterolateral medial; PPM; protocerebral posterior medial; DA; dopamine; IP; immunoprecipita
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse
Keywords: تکرار کیناز 2 غنی از لوسین; α-syn; α-synuclein; ASK1; Apoptosis signaling-regulating kinase 1; CMA; Chaperone-mediated autophagy; DAT; Dopamine transporter; ETC; Electron transport chain; iPS; Induced pluripotent stem; LAMP-2A; Lysosome-associated membrane protein 2A; LB; Lewy bod
LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; Akt1; Parkinson's disease; PARK8;
Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
Keywords: تکرار کیناز 2 غنی از لوسین; Parkinson's disease; Autophagy; Synaptic plasticity; Alpha-synuclein; Parkin; Leucine-rich repeat kinase 2;
LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; B-1 cells; B-2 cells; Parkinson's disease; PARK8; Downregulation
Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis
Keywords: تکرار کیناز 2 غنی از لوسین; Parkinson's disease; Leucine-rich repeat kinase 2; PARK8; Apoptosis;
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; Parkinson's disease; Caenorhabditis elegans; Dopamine; Neurodegeneration
I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule
Keywords: تکرار کیناز 2 غنی از لوسین; Parkinson’s disease; Leucine-rich repeat kinase 2; PARK8; Degradation
Interaction of elongation factor 1-alpha with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro
Keywords: تکرار کیناز 2 غنی از لوسین; Parkinson's disease; leucine-rich repeat kinase 2; elongation factor 1-alpha; GTPase; microtubules; dynamicsCor, C-terminal of Roc; EF1A, elongation factor 1-alpha; LRRK2, leucine-rich repeat kinase 2; MS, mass spectrometry; PBS, phosphate-buffered saline
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
Keywords: تکرار کیناز 2 غنی از لوسین; Leucine-rich repeat kinase 2; Dardarin; Neurodegeneration; Kinase; Movement disorder; Molecular genetic
A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease
Keywords: تکرار کیناز 2 غنی از لوسین; Ubiquitin proteasome system; Parkinson's disease; Alpha-synuclein; Ubiquitin ligase; Substantia nigra; Aggregation; Parkin; Lewy bodies; DJ-1; Leucine-rich repeat kinase 2